Compare · MEC vs ZBH
MEC vs ZBH
Side-by-side comparison of Mayville Engineering Company Inc. (MEC) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- MEC operates in Industrials, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $18.73B, about 30.0x MEC ($624.8M).
- Over the past year, MEC is up 63.1% and ZBH is down 3.3% - MEC leads by 66.4 points.
- ZBH has been more active in the news (8 items in the past 4 weeks vs 5 for MEC).
- ZBH has more recent analyst coverage (25 ratings vs 11 for MEC).
- Company
- Mayville Engineering Company Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $23.25-5.24%
- $99.19+1.03%
- Market cap
- $624.8M
- $18.73B
- 1M return
- -20.09%
- +10.53%
- 1Y return
- +63.12%
- -3.30%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 5
- 8
- Recent ratings
- 11
- 25
Mayville Engineering Company Inc.
Mayville Engineering Company, Inc., together with its subsidiaries, operates as a contract manufacturer that serves the heavy and medium duty commercial vehicle, construction and access equipment, powersports, agriculture, military, and other end markets in the United States. The company provides a range of prototyping and tooling, production fabrication, coating, assembly and aftermarket components. It also supplies engineered components to original equipment manufacturers. The company was founded in 1945 and is headquartered in Mayville, Wisconsin.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest MEC
- SVP, GC & Secretary Leuba Sean P sold $327,031 worth of shares (12,855 units at $25.44), decreasing direct ownership by 66% to 6,633 units (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Mayville Engineering Company Inc.
- SEC Form 10-Q filed by Mayville Engineering Company Inc.
- Mayville Engineering Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Mayville Engineering Company Announces Second Quarter 2026 Results
- Mayville Engineering Company Announces Second Quarter 2026 Results Conference Call and Webcast Date
- SEC Form 11-K filed by Mayville Engineering Company Inc.
- President & CEO Reddy Jagadeesh A sold $549,824 worth of shares (15,688 units at $35.05) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 124,105 units (SEC Form 4)
- President & CEO Reddy Jagadeesh A sold $45,510 worth of shares (1,300 units at $35.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.92% to 139,793 units (SEC Form 4)
- Amendment: President & CEO Reddy Jagadeesh A sold $518,822 worth of shares (17,294 units at $30.00) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 141,093 units (SEC Form 4)
Latest ZBH
- Amendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 4 filed by President, APAC Desai Chintan
- SEC Form 10-Q filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Zimmer Biomet Announces Second Quarter 2026 Financial Results
- Grp Pres-Global Business Thornal Kevin R converted options into 9,957 shares and covered exercise/tax liability with 4,266 shares (SEC Form 4) (tax liability)
- UBS initiated coverage on Zimmer Biomet with a new price target
- SEC Form 3 filed by new insider Desai Chintan
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region